Liver Disease
From the Journals
Supercooling extends donor liver viability by 27 hours
The difference between pre- and postsupercooling energy charge was less than 20%, and bile production, portal resistance, and arterial resistance...
From the Journals
Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality
In sharp contrast with the viral hepatitis findings, mortality rates among patients with ALD and NAFLD have increased.
From the Journals
Type of renal dysfunction affects liver cirrhosis mortality risk
Patients with acute on chronic kidney disease fared the worst.
News
Some HCV medications associated with serious liver injury
In many cases, the medications should never have been prescribed, according to the FDA.
From the Journals
USPSTF issues draft recommendation statement for HCV screening in adults
The proposal represents an update and expansion of USPSTF’s current recommendation.
From the Journals
Lowering portal pressure boosts cirrhosis outcomes
Cirrhosis patients with reduced portal pressure had significantly lower odds of adverse events, liver transplant, and death, irrespective of...
From the Journals
Statins hamper hepatocellular carcinoma in viral hepatitis patients
Two years of daily lipophilic statin use was associated with lower incidence of HCC and reduced all-cause death and liver-related death, compared...
Conference Coverage
The postgraduate course on liver, pancreas, and biliary tract
Each speaker highlighted not only the relevant updates in the literature, but shared the insights into the art of medical practice.
Latest News
Inflammation diminishes quality of life in NAFLD, not fibrosis
In contrast with previous research, lobular inflammation, but not hepatic fibrosis, was associated with worse quality of life.
From the Journals
Spleen/liver stiffness ratio differentiates HCV, ALD
The SS/LS ratio is significantly higher in patients with HCV than in those with alcohol-related liver disease (ALD).